Phillip Sharp

Co-Founder at Alnylam Pharmaceuticals, Inc.

Phillip Sharp

Phillip Sharp

Co-Founder at Alnylam Pharmaceuticals, Inc.

Overview
Career Highlights

Alnylam Pharmaceuticals, Inc.
Biogen, Inc.

RelSci Relationships

6580

Number of Boards

24

Birthday

1945 - Kentucky

Age

75

Number of Awards

6

Relationships
RelSci Relationships are individuals Phillip Sharp likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at REPLIGEN Corp.

Relationship likelihood: Strong

Consulting Professor, Department of Chemistry at Stanford University

Relationship likelihood: Strong

President Emeritus at California Institute of Technology

Relationship likelihood: Strong

Professor & Chairman-Molecular Genetics Department at The University of Texas - Southwestern Medical Center

Relationship likelihood: Strong

Chief Executive Officer, Director at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

President at Stanford University

Relationship likelihood: Strong

Physician in Chief Emeritus of Medicine at The Massachusetts General Hospital

Relationship likelihood: Strong

Rebecca C. Lancefield Professor in Mammalian Cell Biology & Development at The Rockefeller University

Relationship likelihood: Strong

Chairman & Co-Founder at Vir Biotechnology, Inc.

Relationship likelihood: Strong

Co-Founder at Lyndra Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Phillip Sharp
Potential Connections via
Relationship Science
You
Phillip Sharp
Co-Founder at Alnylam Pharmaceuticals, Inc.
Education
PhD in Chemistry
Class of 1969

The University of Illinois at Urbana–Champaign is a public research-intensive university in the U.S. state of Illinois. It is the flagship campus of the University of Illinois system. The University of Illinois at Urbana–Champaign is the second oldest public university in the state (after Illinois State University), and is a founding member of the Big Ten Conference. It is considered a Public Ivy and is a member of the Association of American Universities.

Class of 1969

UIC is a major research university offering the cultural, business and entertainment opportunities you can only find in a world-class city. As one of the top 200 research-funded institutions in the world, UIC faculty discover the things that others teach. Choose from 15 academic colleges including the UIC College of Medicine-the largest in the nation-which educates one in six Illinois physicians. With nearly 2,574 instructional faculty members, there is one faculty member to every 11 students, which allows for a more personal learning experience. What's more, 75 percent of tenured faculty members teach undergraduate courses and 83 percent of full-time instructional faculty have earned a PhD or equivalent. But it's not all work and no play at UIC... Our 16,911 undergrads and 10,669 graduate and professional students make up one of the most diverse student bodies in the United States. Whether living in residence halls, near campus or commuting, you'll find there's always something interesting going on, from social events, clubs, sororities and fraternities, to two state-of-the-art fitness centers, and more-not to mention everything Chicago has to offer just minutes away. And at UIC, we take our sports seriously. The UIC Flames compete in 18 NCAA Division 1 sports and have won a total of 38 conference championships. There's a wide range of intramural teams and sports clubs for students to join.

BA
Class of 1966

PRIVATE COLLEGE

Graduate

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Memberships
Fellow
1983 - Current

Founded in 1780, the American Academy of Arts and Sciences is an independent policy research center that conducts multidisciplinary studies of complex and emerging problems. The Academy’s elected members are leaders in the academic disciplines, the arts, business, and public affairs. With a current membership of 4,000 American Fellows and 600 Foreign Honorary Members, the Academy has four major goals: Promoting service and study through analysis of critical social and intellectual issues and the development of practical policy alternatives; Fostering public engagement and the exchange of ideas with meetings, conferences, and symposia bringing diverse perspectives to the examination of issues of common concern; Mentoring a new generation of scholars and thinkers through the Visiting Scholars Program and Hellman Fellowship Program; Honoring excellence by electing to membership men and women in a broad range of disciplines and professions. Click here to learn about our new members. The Academy's headquarters are in Cambridge, Massachusetts. With its geographically diverse membership, it conducts activities in this country and abroad

Member
Current

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Member
Current

The American Philosophical Society, the oldest learned society in the United States, was founded in 1743 by Benjamin Franklin for the purpose of "promoting useful knowledge." In the 21st century the Society sustains this mission with various programs described further within.

Career History
Co-Founder
2002 - Current

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Senior Scientist
Prior

Cold Spring Harbor Laboratory, Inc. provides research services. It operates educational institutions. The firm offers research in cancer, neurobiology, plant genetics, and bioinformatics. It also offers laboratory workshops to science teachers, students, and other groups across the nation. The company was founded in 1890 and is headquartered in Cold Spring Harbor, NY.

Boards & Committees
Independent Director
2017 - Current

Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.

Member, Board of Directors
2012 - Current

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Member, Board of Directors
2002 - Current

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Chair, Scientific Advisory Committee
Current

Stand Up To Cancer (SU2C) is a charitable program of the Entertainment Industry Foundation under the leadership of the Council of Founders and Advisors (CFA). SU2C is founded on the belief that there is a strong understanding of the basic science of cancer, and with the technologies available, now is the time to take that understanding to the next level by translating this knowledge to the clinic, to real advances in patient care and cancer prevention. It was founded in May 2008.

Member, Board of Directors
Current

The Broad Institute evolved from a decade of informal and successful research collaborations among scientists in the MIT and Harvard communities. In 1990, the Whitehead Institute/MIT Center for Genome Research (WICGR) was founded, and it soon became an international leader in the field of genomics and a flagship of the Human Genome Project. As early as 1995, WICGR scientists recognized the need to bring the power of genomics to the understanding of human disease. It launched pilot projects in genomic medicine, forming an unofficial collaborative network among scientists from across MIT and Harvard who pioneered new approaches to cancer and human genetics. In parallel, Harvard Medical School-based scientists established the Institute of Chemistry and Cell Biology (ICCB) in 1998, to facilitate the pursuit of chemical genetics as an academic discipline and a tool to further understand human biology and disease. In 2002, the ICCB was awarded an Initiative for Chemical Genetics (ICG) grant from the National Cancer Institute, and its successful Investigator-Initiated Screening Program facilitated small molecule screening projects for more than 80 research groups worldwide. These projects demonstrated the power of enabling scientists to collaborate to tackle the major challenges in molecular medicine. It was clear that a new type of formal organization was required — open, collaborative, interdisciplinary, and able to organize projects at any scale. In addition, it was important that the complementary expertise of the genomic scientists and the chemical biologists across MIT and Harvard be brought together in one place to drive the transformation of medicine with molecular knowledge. Discussions in 2002-2003 among Eli and Edythe Broad, MIT, Harvard and its affiliated hospitals, and the Whitehead Institute shaped the vision for this new institute. The extraordinary generosity of Eli and Edythe Broad, through their founding gift of $100 million (later doubled to $200 million) made it possible to formally announce the new institute in June 2003 and to launch it in May 2004. Less than four years after its launch, the Broads gave an unprecedented gift of $400 million in September 2008 to permanently endow the institute, providing long-term sustainability for its unique model of collaborative, inter-institutional research.

Member, Board of Overseers
Current

Boston Symphony Orchestra Inc. performs symphony orchestra concerts. The organization performs concerts in Japan, China, South America, and Europe. The firm offers educational and training programs for professional musicians. The company was founded in 1881 by Henry Lee Higginson and is headquartered in Boston, MA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$15K - $25K
2015

Boston Symphony Orchestra Inc. performs symphony orchestra concerts. The organization performs concerts in Japan, China, South America, and Europe. The firm offers educational and training programs for professional musicians. The company was founded in 1881 by Henry Lee Higginson and is headquartered in Boston, MA.

$1,000 +
2013

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

$5,000 +
2012

The National Academy of Sciences (NAS) formed the Committee on International Security and Arms Control (CISAC) in 1980 as a permanent committee to bring the resources of the Academy to bear on critical problems of international security and arms control. CISAC, in the Policy and Global Affairs Division, draws from the nation’s finest scientific, technical, engineering and medical talent to advise the government, contribute to the work of non-governmental organizations, and inform the public about scientific and technical issues related to international security and arms control. CISAC’s work benefits from a rotating membership of distinguished scientists, policy and military experts. The Committee carries out its mandate through a variety of activities that receive financial support from public and private sponsors.

Investments
Details Hidden

PPD Dermatology LLC develops novel pharmaceutical products and proprietary medical therapies for the dermatology market. The company provides therapies for skin diseases. It was founded in 2006 and is headquartered in Waltham, MA.

Details Hidden

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
1993
Nobel Prize in Physiology or Medicine
Cold Spring Harbor Laboratory - Double Helix Medal
National Medal of Science
Events
Speaker
Davos, Switzerland
2008 World Economic Forum Annual Meeting

The World Economic Forum Annual Meeting 2008 convened in Davos at a time of great anxiety in the world. The turmoil in the financial markets and the continuing conflict in the Middle East were naturally of immediate concern. Mounting awareness of the epochal challenge of climate change and the looming threat of global terrorism, two issues that were addressed in the opening plenary session, heightened our shared sense of urgency. The Annual Meeting theme - The Power of Collaborative Innovation - was a fitting focus for two reasons. First, it highlighted that a multistakeholder approach is critical for any authentic and viable solutions to global problems. And second, it served to underline the need for new and imaginative ways to mitigate global risks and the importance of achieving tangible results or value.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Phillip Sharp. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Phillip Sharp's profile does not indicate a business or promotional relationship of any kind between RelSci and Phillip Sharp.